{"id":"https://openalex.org/W2597035690","doi":"https://doi.org/10.1182/blood.v128.22.189.189","title":"Dynamic Alterations in Gene Expression in Ibrutinib Treated CLL Reveal Profound Impact on Multiple Signaling Pathways","display_name":"Dynamic Alterations in Gene Expression in Ibrutinib Treated CLL Reveal Profound Impact on Multiple Signaling Pathways","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2597035690","doi":"https://doi.org/10.1182/blood.v128.22.189.189","mag":"2597035690"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.189.189","doi":"https://doi.org/10.1182/blood.v128.22.189.189","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.189.189","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066494072","display_name":"Sarah E. M. Herman","orcid":"https://orcid.org/0000-0002-3044-9840","observed_orcids":["https://orcid.org/0000-0002-3044-9840"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sarah E. M. Herman","raw_affiliation_strings":["Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101753966","display_name":"Delong Liu","orcid":"https://orcid.org/0000-0003-4285-3637","observed_orcids":["https://orcid.org/0000-0003-4285-3637"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Delong Liu","raw_affiliation_strings":["Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086217179","display_name":"Dan Avi Landau","orcid":"https://orcid.org/0000-0003-2346-9541","observed_orcids":["https://orcid.org/0000-0003-2346-9541"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan A. Landau","raw_affiliation_strings":["Broad Institute, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073077636","display_name":"Clare Sun","orcid":"https://orcid.org/0000-0001-8498-4729","observed_orcids":["https://orcid.org/0000-0001-8498-4729"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clare Sun","raw_affiliation_strings":["Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104858244","display_name":"Mohammed Z. H. Farooqui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Farooqui","raw_affiliation_strings":["Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047701430","display_name":"Catherine J. Wu","orcid":"https://orcid.org/0000-0002-3348-5054","observed_orcids":["https://orcid.org/0000-0002-3348-5054"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine J Wu","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030524385","display_name":"Adrian U. Wiestner","orcid":"https://orcid.org/0000-0002-3533-2924","observed_orcids":["https://orcid.org/0000-0002-3533-2924"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian Wiestner","raw_affiliation_strings":["Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5066494072","https://openalex.org/A5101753966"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2038,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.59664586,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"189","last_page":"189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gene-expression-changes","display_name":"gene expression changes","score":0.5799999833106995},{"id":"https://openalex.org/keywords/on-target-effects","display_name":"on-target effects","score":0.5730000138282776},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9919999837875366},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.6129999756813049},{"id":"https://openalex.org/keywords/unmutated-ighv","display_name":"unmutated IGHV","score":0.8009999990463257},{"id":"https://openalex.org/keywords/relapsed-refractory-cll","display_name":"relapsed/refractory CLL","score":0.847000002861023},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.550000011920929},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9820517301559448},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.6699532270431519},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6133204698562622},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.609588623046875},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5276542901992798},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49577197432518005},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4720730781555176},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.46539413928985596},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38942861557006836},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3886171579360962},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3182210922241211},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15689876675605774}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.189.189","doi":"https://doi.org/10.1182/blood.v128.22.189.189","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.189.189","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W143275086","https://openalex.org/W2267257595","https://openalex.org/W3149259066","https://openalex.org/W2528888296","https://openalex.org/W4389231190","https://openalex.org/W2950767934","https://openalex.org/W3111225512","https://openalex.org/W2750936883","https://openalex.org/W2899536380","https://openalex.org/W2255241835"],"abstract_inverted_index":{"Abstract":[0],"Ibrutinib":[1],"covalently":[2],"binds":[3],"Bruton":[4],"tyrosine":[5],"kinase":[6],"(BTK)":[7],"leading":[8],"to":[9,249,276,313,415,487,603],"sustained":[10],"target":[11],"inhibition.":[12],"On-target":[13],"effects":[14,536],"include":[15],"reductions":[16],"in":[17,50,76,188,257,263,333,462,477,525,528,531,574,601],"BCR":[18,432,486],"and":[19,22,27,39,54,68,123,152,168,233,291,296,304,406,433,449,503,515,571,615,627],"NF-\u03baB":[20,434],"signaling":[21,435,497],"inhibition":[23,429,455,494,567,586],"of":[24,43,84,99,133,175,205,320,430,445,453,459,493,495,501,513,553,559,568,610,623,632,645,659],"tumor":[25,95,546,576,626],"proliferation":[26],"survival":[28,42],"(Herman,":[29],"Blood":[30,193,425],"2014).":[31],"In":[32,356,519],"randomized":[33],"trials,":[34],"ibrutinib":[35,105,129,367,521,604],"induced":[36],"superior":[37],"responses":[38],"extended":[40],"the":[41,52,77,82,131,203,238,317,324,334,338,412,443,446,451,457,468,496,575,583,608,619,624,628,641,646],"patients":[44,70,101],"with":[45,103,265,271,337,582,588,618],"chronic":[46],"lymphocytic":[47],"leukemia":[48],"(CLL)":[49],"both":[51,294,431],"relapsed/refractory":[53],"frontline":[55],"setting":[56],"(Byrd,":[57],"NEJM":[58,61],"2014;":[59],"Burger,":[60],"2015).":[62],"However,":[63],"deep":[64],"remissions":[65],"are":[66],"uncommon":[67],"most":[69],"have":[71],"readily":[72],"detectable":[73],"residual":[74,625],"disease":[75,86],"blood.":[78],"To":[79,215,315],"better":[80],"understand":[81],"biology":[83,547],"persistent":[85],"on":[87,92,128,354,366,545,655],"ibrutinib,":[88,388],"we":[89,221,322,594],"performed":[90],"RNA-sequencing":[91],"CD19+":[93],"selected":[94,222],"cells":[96,530,633],"from":[97,212,456,481,550],"14":[98],"86":[100],"treated":[102,463],"single-agent":[104],"(ClinicalTrials.gov":[106],"NCT01500733);":[107],"8/14":[108,114],"(57%)":[109,115],"had":[110,116,126,155],"an":[111,656],"unmutated":[112],"IGVHsequence,":[113],"del(17p),":[117,514],"6/14":[118],"(43%)":[119],"were":[120,161,243,279,351,362,384],"previously":[121],"untreated":[122],"4/14":[124],"(29%)":[125],"relapsed":[127],"at":[130,226,284,288,293,307],"time":[132],"analysis":[134,180,414],"(range:":[135],"8-47":[136],"months).":[137],"At":[138],"best":[139],"response,":[140,397],"3/14":[141],"(21%)":[142],"achieved":[143],"a":[144,148,173,189,228,266,482,542,611],"CR,":[145],"10/14":[146],"(71%)":[147],"PR":[149],"or":[150,310,511,661],"PRL":[151],"1/14":[153],"(7%)":[154],"SD.":[156],"Three":[157],"samples":[158,183,209,235,253],"per":[159,379],"patient":[160],"analyzed:":[162],"T1":[163],"(baseline),":[164],"T2":[165,261,285,295,309],"(day":[166],"28)":[167],"T3":[169,252,289,311],"(6":[170],"months),":[171],"for":[172,197,485,489],"total":[174],"42":[176],"samples.":[177,466],"Principal":[178],"component":[179],"(PCA)":[181],"grouped":[182],"by":[184,387,441,640],"patient,":[185],"as":[186],"observed":[187,587,629],"similar":[190],"study":[191],"(Herishanu,":[192],"2011).":[194],"After":[195],"adjusting":[196],"patient-specific":[198],"effects,":[199],"PCA":[200],"clearly":[201],"revealed":[202],"effect":[204],"treatment,":[206,321],"separating":[207],"on-treatment":[208,247],"(T2,":[210],"T3)":[211],"baseline":[213,232,465],"(T1).":[214],"identify":[216,316],"differentially":[217],"expressed":[218,283],"(DE)":[219],"genes,":[220,241,301],"transcripts":[223],"that":[224,540],"showed":[225],"least":[227],"2-fold":[229],"change":[230],"between":[231],"treatment":[234,269,517,590],"(FDR<0.1).":[236],"Of":[237,467],"~14,000":[239],"measured":[240],"there":[242,278],"653":[244],"DE":[245,281,300],"genes":[246,282,378,448],"compared":[248,312],"baseline.":[250],"Notably,":[251],"demonstrated":[254,474],"stronger":[255],"changes":[256,327,524,560,573],"gene":[258,325,330,359,419,526],"expression":[259,326,444,527],"than":[260,548],"samples,":[262],"line":[264],"more":[267,370,584],"profound":[268,585],"response":[270,602,614],"continued":[272],"drug":[273],"exposure.":[274],"Compared":[275],"T1,":[277],"80":[280],"only,":[286,290],"330":[287],"243":[292],"T3.":[297],"Among":[298],"all":[299,473],"498":[302],"decreased":[303],"155":[305],"increased":[306],"either":[308],"T1.":[314],"biologic":[318,502,598],"impact":[319,544],"dissected":[323],"using":[328],"pathway-specific":[329],"signatures":[331,340,360,420],"represented":[332],"KEGG":[335,382],"pathways":[336,350,383,498,539,564],"molecular":[339],"database":[341],"tool":[342],"(MSigDB;":[343],"Broad":[344],"Institute,":[345],"Boston,":[346],"MA).":[347],"Strikingly,":[348],"no":[349,596],"significantly":[352,363,385,470],"enriched":[353],"treatment.":[355],"contrast,":[357],"multiple":[358,538,562],"(n=46)":[361],"turned":[364],"down":[365],"(FDR<0.01).":[368],"Using":[369],"stringent":[371],"cutoffs":[372],"(p<0.0005;":[373],"FDR":[374],"q<0.005;":[375],"\u22655":[376],"significant":[377,428],"pathway),":[380],"nine":[381],"inhibited":[386],"including":[389,506],"cytokine":[390],"signaling,":[391,399,405],"cell":[392,400],"adhesion,":[393,403],"systemic":[394],"lupus,":[395],"p53":[396],"MAPK":[398],"cycle,":[401],"focal":[402],"calcium":[404],"Wnt":[407],"signaling.":[408],"We":[409,437],"also":[410],"applied":[411],"same":[413],"experimentally-derived":[416],"B":[417],"cell-specific":[418],"(Shaffer,":[421],"Immunity":[422],"2001;":[423],"Herishanu,":[424],"2011),":[426],"demonstrating":[427],"pathways.":[436],"derived":[438],"signature":[439,460,478],"scores":[440],"averaging":[442],"signature-specific":[447],"estimated":[450],"degree":[452,492],"pathway":[454],"ratio":[458],"averages":[461],"versus":[464],"11":[469],"altered":[471],"pathways,":[472],">50%":[475],"reduction":[476,484],"scores,":[479],"ranging":[480],"71%":[483],"54%":[488],"p53.":[490],"The":[491,556],"was":[499,638],"independent":[500],"clinical":[504],"features,":[505],"IGVH":[507],"mutation":[508],"status,":[509],"presence":[510],"absence":[512,609],"prior":[516],"status.":[518],"summary,":[520],"induces":[522],"widespread":[523],"CLL":[529],"vivo":[532],"reflecting":[533],"strong":[534],"inhibitory":[535],"across":[537,561],"suggest":[541],"broader":[543],"expected":[549],"pure":[551],"loss":[552],"BTK":[554],"function.":[555],"surprising":[557],"extent":[558],"diverse":[563],"could":[565],"reflect":[566],"tumor-microenvironment":[569],"crosstalk":[570],"consequent":[572],"milieu.":[577],"This":[578,636],"notion":[579],"is":[580,616],"consistent":[581,617],"longer":[589],"duration.":[591],"Equally":[592],"notable,":[593],"found":[595],"distinct":[597],"signature(s)":[599],"upregulated":[600],"which":[605],"may":[606],"indicate":[607],"cellular":[612],"stress":[613],"apparent":[620],"resting":[621],"state":[622],"slow":[630],"attrition":[631],"over":[634],"time.":[635],"research":[637],"supported":[639],"Intramural":[642],"Research":[643,667,671],"Program":[644],"NHLBI.":[647],"Disclosures":[648],"Farooqui:":[649],"Merck:":[650],"Employment.":[651],"Wu:Neon":[652],"Therapeutics:":[653],"Membership":[654],"entity's":[657],"Board":[658],"Directors":[660],"advisory":[662],"committees,":[663],"Other:":[664],"Co-founder.":[665],"Wiestner:Pharmacyclics:":[666],"Funding;":[668],"Acerta":[669],"Pharma:":[670],"Funding.":[672]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-23T00:00:00"}